This site is intended for healthcare professionals

Opthea finalizes study designs for the phase III ShORe and COAST pivotal clinical trials of OPT 302 in wet age-related macular degeneration.

Read time: 2 mins
Last updated:30th Jul 2021
Published:9th Mar 2021
Condition: Age Related Macular Degeneration
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest